Hudson Bay Capital Management LP Madrigal Pharmaceuticals, Inc. Transaction History

Hudson Bay Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $2.97 Million - $3.95 Million	12,850 New	12,850 $3.11 Million
Q2 2018 Aug 13, 2018	SELL	$101.55 - $313.9 $4.57 Million - $14.1 Million	-45,000 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$93.35 - $149.04 $1.4 Million - $2.24 Million	15,000 Added 50.0%	45,000 $5.26 Million
Q4 2017 Feb 12, 2018	BUY	$39.35 - $97.37 $1.18 Million - $2.92 Million	30,000	30,000 $2.75 Million

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.42B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.